Australia's BluGlass rises after signing agreement with US firm

By Reuters News

** Shares of BluGlass BLG.AX rise as much as 12.2% to A$0.275, their highest since September 9

** Stock logs its largest intraday pct gain since August 31

** Semiconductor developer enters into early-stage collaboration with US-based photonics co Coherent COHR.N for the development of gallium nitride device used in microscopes, MRI systems and in the telecommunications sector

** Collaboration valued at A$286,000 ($203,832.20), with the initial feasibility study expected to run for three to five months

** Jointly developed device is being designed to address emerging scientific and medical applications requiring high-performance visible-wavelength laser technology - Co

** YTD, stock up over 6%

($1 = 1.4031 Australian dollars)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk